Product Information
SODIUM CHLORIDE 0.9% VIAL is a generic product labeled by Hospira Inc., priced at $0.0887 per ML under NDC 00409488812. Its NADAC has been published 489 times since Nov 28, 2013.
FDA first approved this application on Oct 29, 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
9 mg/mL
Manufacturer
Hospira Inc.NDC
00409488812
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
SODIUM CHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA018803FDA Approved
10/29/1982
TE Code
AP
On Market Since
2/28/2005
Price Statistics
The NADAC for SODIUM CHLORIDE 0.9% VIAL has been published 489 times since Nov 28, 2013, and over the history we have for it it has risen 32.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0887 per ML |
|---|---|
| All-time high | $0.0889 (Mar 12, 2025) |
| All-time low | $0.0534 (Feb 18, 2015) |
| 52-week high | $0.0888 |
| 52-week low | $0.0814 |
| Median price | $0.0786 |
| Average price | $0.0769 |
| Largest weekly change | +38.5% (Mar 18, 2015) |
| Weeks tracked | 489 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sodium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SODIUM CHLORIDE 0.9% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SODIUM CHLORIDE 0.9% VIAL, manufactured by Hospira Inc., is $0.0887 per ML (NDC 00409488812), effective Sep 30, 2026.
How has the price of SODIUM CHLORIDE 0.9% VIAL changed over time?
Over the history we have for it, the NADAC for SODIUM CHLORIDE 0.9% VIAL has risen 32.3%. It has been tracked across 489 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SODIUM CHLORIDE 0.9% VIAL?
Since Nov 28, 2013, the NADAC for SODIUM CHLORIDE 0.9% VIAL has ranged from a low of $0.0534 (Feb 18, 2015) to a high of $0.0889 (Mar 12, 2025), with a median of $0.0786 per ML.
Are there cheaper alternatives to SODIUM CHLORIDE 0.9% VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SODIUM CHLORIDE 0.9% SOLUTION, is $0.0021 per ML — about 98% below SODIUM CHLORIDE 0.9% VIAL.
Who manufactures SODIUM CHLORIDE 0.9% VIAL?
SODIUM CHLORIDE 0.9% VIAL (NDC 00409488812) is labeled by Hospira Inc., and CMS classifies it as a generic product.